BSEBoard MeetingResults1d ago
Privi Speciality Chemicals Ltd
Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Intimation of Board Meeting to be held on Thursday, October 29, 2026.
Privi Speciality Chemicals Ltd has scheduled a Board Meeting on October 29, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026, and to consider recommending a first interim dividend for the financial year 2026-27.
BSECompany Update7 Oct 2026
Privi Speciality Chemicals Ltd
Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026.
Privi Speciality Chemicals Ltd has received a Certificate under Regulation 74(5) of SEBI (Depository & Participants) Regulations, 2018 for the second quarter ended September 30, 2026.
BSECompany UpdateM&A6 Oct 2026
Privi Speciality Chemicals Ltd
Notice of Hon''ble NCLT Convened Shareholders Meeting in the matter of Scheme of Amalgamation, Scheduled to be held on Tuesday, October 27, 2026 At 12:30 p.m.
Privi Speciality Chemicals Ltd has received a notice from the Hon'ble National Company Law Tribunal, Mumbai Bench, convening a meeting of its equity shareholders to consider the Scheme of Amalgamation with Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited. The meeting is scheduled to be held on October 27, 2026.
BSEInsider Trading / SASTRelated Party25 Sept 2026
Privi Speciality Chemicals Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Funds
Privi Speciality Chemicals Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from SBI Mutual Funds.
BSECompany UpdateRegulatory25 Sept 2026
Privi Speciality Chemicals Ltd
Newspaper Publication of Notice Convening Meeting of Equity Shareholders (Meeting) of the Company Convened in accordance with the order of the Hon''ble National Company Law Tribunal, Mumbai Bench.
Privi Speciality Chemicals Ltd has published a notice convening a meeting of equity shareholders in accordance with an order from the National Company Law Tribunal, Mumbai Bench.
BSEAGM/EGMM&A24 Sept 2026
Privi Speciality Chemicals Ltd
Notice of Meetinfg of Equity Shareholders (Meeting) of the Company convened in accordance with the order of the Hon''ble National Company Law Tribunal, Mumbai Bench, to be held through Video Conferencing (VC)/ Other Audio - Visual Means (OVAM) on Tuesday, October 27,2026 at 12.30 p.m
Privi Speciality Chemicals Ltd has convened a meeting of equity shareholders in accordance with the order of the Hon'ble National Company Law Tribunal, Mumbai Bench, to consider the proposed Scheme of Amalgamation with Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited.
BSEInsider Trading / SASTResults24 Sept 2026
Privi Speciality Chemicals Ltd
Intimation of Closure of Trading Window for the second quarter and half year ending September 30,2026.
Privi Speciality Chemicals Ltd has announced the closure of its trading window for the second quarter and half year ending September 30, 2026, due to the upcoming declaration of un-audited financial results.
BSECompany Update11 Aug 2026
Privi Speciality Chemicals Ltd
Intimation of Schedule of Analyst / Institutional Investor Meeting to be held on August 18,2026.
Privi Speciality Chemicals Ltd announces the schedule of Analyst/Institutional Investor meetings to be held on August 18, 2026, in Mumbai. The meeting will discuss publicly available information, and no unpublished price-sensitive information will be disclosed.
BSEAGM/EGM10 Aug 2026
Privi Speciality Chemicals Ltd
Scrutinizer''s Report on the voting results of the business transacted at the 41st Annual General Meeting (AGM)
Privi Speciality Chemicals Ltd has released the Scrutinizer's Report on the voting results of the 41st Annual General Meeting (AGM) held on August 07, 2026.
BSEAGM/EGM7 Aug 2026
Privi Speciality Chemicals Ltd
Summary of the Proceedings of 41st (Forty First) Annual General Meeting of the Company held on Friday August 07,2026.
The 41st Annual General Meeting (AGM) of Privi Speciality Chemicals Ltd was held on August 7, 2026, through video conferencing, with the Chairman and Managing Director, Mahesh Purshottam Babani, chairing the meeting. The meeting was attended by the Board of Directors, senior management personnel, and representatives of the statutory auditors and secretarial auditors. The AGM was conducted in compliance with regulatory requirements, and the company provided remote e-voting facilities for shareholders. The meeting was held without any qualifications, observations, or adverse remarks from the statutory auditors and secretarial auditors.
BSECompany Update▲ PositiveResults3 Aug 2026
Privi Speciality Chemicals Ltd
Transcript of Earning Call held on Friday July 31, 2026.
Privi Speciality Chemicals Ltd has announced its Q1 FY27 earnings, with revenue of Rs. 666 crore, a 19.22% year-on-year growth. The company reported healthy demand across both domestic and international markets, despite adverse global headwinds. The management emphasized the importance of executing the expansion projects, strengthening the specialty product portfolio, and building on long-standing customer relationships.
BSECompany UpdateResults31 Jul 2026
Privi Speciality Chemicals Ltd
Audio Recording of Analyst/ Investors Meet held on Friday July 31,2026.
Privi Speciality Chemicals Ltd has announced the audio recording of its analysts/investors meet held on July 31, 2026, to discuss the un-audited standalone and consolidated financial results for the first quarter ended June 30, 2026.
BSECompany Update▲ PositiveResults30 Jul 2026
Privi Speciality Chemicals Ltd
Investors Presentation - Financial and Operation Review for quarter ended June 30,2026.
Privi Speciality Chemicals Ltd has reported a strong start to the year with 20.01% year-on-year growth in total income, 18.73% year-on-year growth in EBITDA, and 35.97% year-on-year growth in Net Profit. The company has also mentioned that it has filed for insurance claim for a fire incident at a CFS warehouse near JNPT costing Rs 2.78 cr.
BSEResultResults30 Jul 2026
Privi Speciality Chemicals Ltd
Unaudited Financial Results for the Quarter ended June 30,2026.
Privi Speciality Chemicals Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company's board of directors has considered, approved, and taken on record the unaudited standalone and consolidated financial results for the quarter, along with the limited review reports from the statutory auditors. The results are available on the company's website.
BSEBoard MeetingResults30 Jul 2026
Privi Speciality Chemicals Ltd
Outcome of the Board Meeting held today i.e Thursday July 30,2026 for approval of unaudited standalone and consolidated Financial Results of the Company for quarter ended June 30,2026.
Privi Speciality Chemicals Ltd has announced the outcome of its board meeting held on July 30, 2026, where the board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the limited review reports from the statutory auditors.
BSECompany UpdateResults23 Jul 2026
Privi Speciality Chemicals Ltd
Announcement under Regulation 30 (LODR) - Analyst / Investor Meet- Intimation of Q1 Earnings call.
Privi Speciality Chemicals Ltd has announced an earnings conference call to discuss its operational and financial performance for the first quarter ended June 30, 2026. The call will be held on July 31, 2026, at 3:30 p.m. IST, and a transcript will be available on the company's website within five working days.
BSEBoard MeetingResults22 Jul 2026
Privi Speciality Chemicals Ltd
Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Intimation of Board ....
Privi Speciality Chemicals Ltd has scheduled a Board Meeting on July 30, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.